期刊文献+

CD4^+CD25^+调节性T细胞防治移植物抗宿主病的研究进展 被引量:2

Research progress of CD4^+ CD25^+ regulatory T cells for the prevention and treatment of GVHD
原文传递
导出
摘要 异基因造血干细胞移植是目前治疗白血病、淋巴瘤等恶性血液疾病的有效手段,但是其疗效却受到了移植后发生的移植物抗宿主病的制约与限制。近年来,随着对CD4^+CD25^+调节性T细胞(Treg)研究的深入,人们发现这一T细胞亚群不仅在维持免疫自稳和抑制异体免疫应答方面具有重要作用,并且对于预防与治疗移植物抗宿主病也有一定的潜力。 However allo-hematopoietie stem cell transplantation is the crucial treatment of hematologic malignant diseases sueh as Leukemia and lymphoma, the curative effeet of HSCT is hampered by the ineidenee of GVHD after transplantation. In recent years, with the development of CD4^+ CD25^+ regulatory T cells study, researchers have realized this T cell subset not only play an essential role in maintenance of immune homeostasis and inhibition of allograft immune response, but for the prevention and treatment of GVHD also has certain po- tential. This article foeuses on the biological features of regulatory T eells and the research development of it for prevention and treatment of GVI-ID.
出处 《国际免疫学杂志》 CAS 2012年第6期461-465,共5页 International Journal of Immunology
关键词 调节性T细胞 移植物抗宿主病 造血干细胞移植 Regulatory T cells Graft-versus-host disease Hematopoietie stem cell transplantation
  • 相关文献

参考文献31

  • 1Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol, 2007, 7 (5) ':340-352.
  • 2徐佳,侯桂华.移植免疫耐受中调节性T细胞的研究进展[J].国际免疫学杂志,2007,30(6):393-398. 被引量:5
  • 3Sakaguchi S, Sakaguchi N, Asano M, et al. Imunologic self-toler- ance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25). Breakdown of a single mechanism of Self-tolerance causes various autoimmune diseases. J Immunol, 1995,155 ( 3 ) : 1151-1164.
  • 4Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the de- velopment and function of CD4 + CD25 + regulatory T cells. Nat Immunol, 2003, 4(4) :330-336.
  • 5Toda A, Piccirillo CA. Development and function of naturally oc- curring CD4 + CD25 + regulatory T ceils. J Leukoe Biol, 2006,80 (3)" :458-470.
  • 6Chatenoud L. Natural and induced T CIM + CD25 + FOXP3 + regulatory T ceils. Methods Mol Biol, 2611,677:3-13.
  • 7Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage. Nat Rev Immunol, 2009, 9 (2) :83-89.
  • 8Floess S, Freyer J, Siewert , et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol,2007,5 (2) : 169- 178.
  • 9O' Garra A, Vieira P. Regulatory T cells and mechanisms of im-mune system eontrol. Nat Med, 2004,10(8) :801-805.
  • 10Yeung MY, Sayegh MH. Regulatory T cells in transplantation: what we know and what" we do not know. Transplant Proc,2009, 41 (6) :$21-26.

二级参考文献20

  • 1蔡永君,孙文佶(审校).固有CD4^+CD25^+调节性T细胞与其在移植耐受上的进展[J].国际免疫学杂志,2006,29(3):196-200. 被引量:2
  • 2Fontenot JD, Rasmussen JP, Williams LM, et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity ,2005,22( 3 ) :329-341.
  • 3Banham AH. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3 ( + ) regulatory T cells. Trends Immunol, 2006,27 (12) :541-544.
  • 4Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol,2003,3 ( 3 ) :253-257.
  • 5Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4^+ CD25- naive T cells to CD4^+ CD25^+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med,2003,198 (12) :1875-1886.
  • 6Maile R, Pop SM, Tisch R, et. al. Low-avidity CD8loT cells induced by incomplete antigen stimulation in vivo regulate naive higher aviditxy CD8hi T cell responses to the same antigen. Eur J Immunol,2006,36 (2) :397-410.
  • 7Young KJ, DuTemple B, Phillips M J, et al. Inhibition of Graft-Versus-Host Disease by Double-Negative Regulatory T Ceils. J Immunol, 2003,171 : 134-141.
  • 8Chen W, Zhou D, Torrealba JR, et al. Donor Lymphocyte Infusion Induces Long-Term Donor-Specific Cardiac Xenograft Survival through Activation of Recipient Double-Negative Regulatory T Ceils. J Immunol,2005,175 (5) : 3409-3416.
  • 9Lee BP, Chen W, Shi H, et al. CXCRS/CXCL13 Interaction Is Important for Double-Negative Regulatory T Cell Homing to Cardiac Allografts. J Immunol,2006,176(9) :5276-5283.
  • 10Jiang X, Kojo S, Harada M,et al. Mechanism of NKT cell-mediated transplant tolerance. Am J Transplant,2007,7 (6) :1482-1490.

共引文献4

同被引文献48

  • 1张颢,龚伟,孟磊,池颖,张浪辉,陈志哲,刘拥军,韩忠朝.脐带间充质干细胞对T细胞的免疫调控研究[J].中国免疫学杂志,2007,23(12):1102-1105. 被引量:15
  • 2任红英,赵钦军,邢文,杨少光,卢士红,任倩,张磊,韩忠朝.脐带间充质干细胞体外分化为有功能的低免疫原性肝细胞样细胞[J].中国医学科学院学报,2010,32(2):190-194. 被引量:24
  • 3尤平洪,卢一平.一种新型的IL-2R受体阻滞剂——抗CD25单克隆抗体[J].华西医学,2007,22(3):659-660. 被引量:7
  • 4Choi SW, Reddy P. Current and emerging strategies for the preven- tion ofgraft-versus-host disease [ J ]. Nat Rev Clin Oncol, 2014,11 (9) :536-547.
  • 5Li Z, Li D, Tsun A, et al. FOXP3 + regulatory T ceils and their functional regulation [ J ]. Cell Mol Immunol. 2015 Feb 16. doi: 10. 1038/cmi. 2015,10.
  • 6Perez L,Anasetti C,Pidala J. Have we improved in preventing and treating acute graft-versus-host disease [ J ]. Curt Opin Hematol, 2011,18(6) :408-413.
  • 7Sellar RS, Peggs KS. Recent progress in managing graft-versus-host disease and viral infections following allogeneic stem cell transplan- tation[J]. Future Oncol,2012,8(12) :1549-1565.
  • 8Chen YB,Cutler CS. Biomarkers for acute GVHD: can we predict the unpredictable[J]? Bone Marrow Transplant,2013,48(6) :755-760.
  • 9Sawamukai N, Satake A, Schmidt AM, et, al. Ceil-autonomous role of TGF and IL-2 receptors in CIM + and CD8+ inducible regula- tory T-cell generation during GVHD [ J ]. Blood, 2012,119 ( 23 ) : 5575-5583.
  • 10Levine JE,Logan BR,Wu J, et al. Acute graft-versus-host disease biomarkers measured during therapy can predict treatment out- comes: a Blood and Marrow Transplant Clinical Trials Network study[J]. Blood,2012,119(16) :3854-3860.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部